Stocks and Investing
Stocks and Investing
Fri, January 31, 2014
[ 12:00 AM ] - WOPRAI
Thu, January 30, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 29, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 28, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $50 on, Jan 28th, 2014
Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $47 to $50 on, Jan 28th, 2014.
Liav has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Liav's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014
This is the rating of the analyst that currently disagrees with Liav
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $38 on, Monday, November 4th, 2013